"A Choice Backed by 150 Years of Experience"... SHIMADZU and GENORAY Sign Global Partnership Supply Agreement

GENORAY (CEO Byung-wook Park), a company specializing in X-ray imaging diagnostic medical devices, announced that it has signed a large-scale ODM agreement to supply Mobile C-Arms to the Japanese precision instrument manufacturer SHIMADZU Corporation. Through this agreement, GENORAY will, starting from the third quarter of 2026...

Author Image
GENORAY
April 30, 2026
Blog Image


 

GENORAY (CEO Byung-wook Park), a company specializing in X-ray imaging diagnostic medical devices, announced that it has signed a large-scale ODM agreement to supply Mobile C-Arms to the Japanese precision instrument manufacturer SHIMADZU Corporation. Through this agreement, GENORAY has secured a foundation for product sales and revenue generation through SHIMADZU's global network starting in the third quarter of 2026.

SHIMADZU is a global precision instrument company that successfully performed Japan's first X-ray imaging in 1896. It currently employs over 14,000 people worldwide, generates more than 5 trillion KRW in annual revenue, with over 50% of its sales coming from overseas, and maintains a sales network in more than 100 countries. Known as a "master of X-ray technology" in the industry, it is backed by manufacturing expertise and quality verification systems accumulated in the fields of medical imaging and analytical equipment.

GENORAY is also a specialized company that has focused on the X-ray imaging diagnostic medical device sector for 25 years, supplying products to over 80 countries worldwide. In particular, the Mobile C-Arm is one of GENORAY's core product lines and has established itself as a flagship item driving the expansion of overseas sales. Having pursued product registration and market-specific entry procedures in parallel since obtaining CE MDR certification, the company explains that this ODM agreement with SHIMADZU marks a transition from simple technical cooperation to a state of readiness for actual sales.

A GENORAY representative stated, "This agreement is significant in that it recognizes the technological prowess and quality competitiveness of our Mobile C-Arms in the global market, and secures a foundation for tangible revenue generation based on our MDR certification and sales preparations," adding, "We plan to accelerate our overseas sales, starting with distribution through SHIMADZU's global network."